DAHANCA 9 – a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC)

Authors

  • Jan Folkvard Evensen Norwegian Radium Hospital, Oslo, Norway
  • Hanne Sand Hansen Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
  • Marie Overgaard Department of Oncology, Aarhus University Hospital, Aarhus N, Denmark
  • Jørgen Johansen Department of Oncology, Odense University Hospital, Odense C, Denmark
  • Lisbeth Juhler Andersen Department of Oncology, Aalborg University Hospital, Aalborg, Denmark
  • Jens Overgaard Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark

DOI:

https://doi.org/10.1080/0284186X.2019.1629012

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2019-10-03

How to Cite

Folkvard Evensen, J., Sand Hansen, H., Overgaard, M., Johansen, J., Juhler Andersen, L., & Overgaard, J. (2019). DAHANCA 9 – a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC). Acta Oncologica, 58(10), 1502–1505. https://doi.org/10.1080/0284186X.2019.1629012

Issue

Vol. 58 No. 10 (2019): Acta Oncologica

Section

Articles